市販直後調査における副作用報告の評価―ニューキノロン系抗菌剤における比較検討―:—ニューキノロン系抗菌剤における比較検討—
スポンサーリンク
概要
- 論文の詳細を見る
Objective: The purpose of this study is to identify the problems in the adverse drug report (ADR) system in early post-marketing vigilance phase (EPM phase) in Japan.Methods: The incidence of all ADRs and the ratio of serious ADRs were compared between the new drug application phase (ND phase) and the EPM phase. The target medicines were Moxifloxacin (Avelox®tablets, 400mg), Gatifloxacin (Gatiflo®tablets, 100mg) and Prulifloxacin (Sword®tablets, 100mg).Results: The average incidence of all ADRs in the ND phase was 100-fold greater than that in the EPM phase. There were also 2-fold differences in the ratio of serious ADRs of individual medicines.Conclusion: There are several problems with the ADR system in the EPM phase in Japan. It is currently possible that the implementation of EPM will vary between in individual medicines and companies. This suggests that the present data cannot be applied universally. Thus, there is an urgent need to standardize the implementation of EPM.
- 日本医薬品情報学会の論文
日本医薬品情報学会 | 論文
- 一般用医薬品の添付文書理解度調査法の開発:―理解度への影響因子の検討―
- 汎用データベースソフトを用いた持参薬識別システムの構築と有用性の検討
- 実務実習生の医薬品情報リテラシー向上を目的とした医薬品情報実習の効果
- 医療用および一般用医薬品を対象としたドーピング防止早見表の作成
- Preparation of Quick Reference Table on Incompatibilities of Injections for Use in the ICU and Investigation of the Usefulness of This Table